Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2022-07-13 00:00:00 ET · period of report 2022-07-11 · accession 0001209191-22-042037 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-13 | 2022-07-11 | PCRX | HASTINGS PAUL J | Dir | S - Sale | $56.95 | -533 | 7,179 | -7% | -$30.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-11 | S | D | 533 | $56.95 | 7,179 | D | — | — | (F2) Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. |